How Shifting Trade Dynamics Are Reshaping U.S. Healthcare | Life Sciences Snapshot – Q2 2025
11 minute read | May.12.2025
Partner
Los Angeles
David Gindler is Global Co-Leader of Orrick’s Life Sciences & HealthTech Sector. An experienced trial attorney, he focuses on intellectual property litigation and licensing, with a strong emphasis on trials of high-stakes patent and trade secret disputes in the life sciences field. David’s exceptional record has earned him repeat honors by Chambers USA. He has been Chambers-ranked for 15 years and is currently ranked Band 2 for Life Sciences: IP/Patent Litigation in both the USA Nationwide and California editions.
David has achieved extraordinary trial outcomes for both plaintiffs and defendants, including a $302 million verdict for breach of a research and license agreement covering foundational biotechnology, as well as defeating a $217 million damages claim in a patent dispute where liability had already been established in an earlier trial handled by a different law firm. David also negotiates complex intellectual property license agreements involving cutting-edge technologies and creative financial structures, frequently working on behalf of leading academic institutions.
David is a passionate supporter of the nonprofit performing arts community. He is a past member of the boards of directors of the Los Angeles Philharmonic, Center Theatre Group, The Music Center, Los Angeles Master Chorale, Antaeus Theatre Company and Beth Morrison Projects.
David is a Member of the Litigation and Intellectual Property Law Sections of the American Bar Association, the State Bar of California and the Los Angeles County Bar Association. Mr. Gindler is also a member of the Federal Circuit Bar Association, the American Intellectual Property Law Association, and the Los Angeles Intellectual Property Law Association.
Select prior experience includes:
11 minute read | May.12.2025
11 minute read | February.19.2025
4 minute read | November.15.2022